Araja, Diana, Krumina, Angelika, Nora-Krukle, Zaiga et al. · Vaccines · 2022 · DOI
Researchers analyzed publicly available European vaccine safety reports to see which health problems were most commonly reported after COVID-19 vaccination. They found that the most frequently reported issues involved general symptoms (like injection site reactions and fever), nervous system problems (like headaches), and muscle/joint pain. The study notes that while ME/CFS wasn't specifically tracked in the database, reports of chronic fatigue syndrome were present and could be studied.
This study is important because it systematically documents patterns of reported adverse reactions across vaccine types in a large European database, which helps identify potential safety signals that may warrant closer investigation. For ME/CFS patients and researchers, the observation that musculoskeletal and nervous system disorders are among the most commonly reported post-vaccination conditions creates a foundation for more targeted investigation of post-vaccination symptom clusters that may overlap with ME/CFS presentations.
This study does not establish causation between vaccines and reported conditions—it only catalogs what healthcare workers and patients reported. The data reflects reported adverse events, not confirmed vaccine-caused illness, and reporting bias may systematically over- or under-represent certain conditions. Additionally, the study does not specifically investigate ME/CFS etiology or prevalence, only notes that chronic fatigue syndrome reports exist in the database.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Araja, Diana, Krumina, Angelika, Nora-Krukle, Zaiga, Berkis, Uldis, & Murovska, Modra (2022). Vaccine Vigilance System: Considerations on the Effectiveness of Vigilance Data Use in COVID-19 Vaccination.. Vaccines. https://doi.org/10.3390/vaccines10122115
BibTeX
@article{mecfsatlas-araja-2022-vaccine-vigilance,
author = {Araja, Diana and Krumina, Angelika and Nora-Krukle, Zaiga and Berkis, Uldis and Murovska, Modra},
title = {Vaccine Vigilance System: Considerations on the Effectiveness of Vigilance Data Use in COVID-19 Vaccination.},
journal = {Vaccines},
year = {2022},
doi = {10.3390/vaccines10122115},
note = {PubMed: 36560525},
url = {https://www.mecfsatlas.com/evidence/araja-2022-vaccine-vigilance},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-05-29. https://www.mecfsatlas.com/evidence/araja-2022-vaccine-vigilance
Contribute
Private, reviewed by a human. Not a public comment thread.